SECTION 1. Section 34A of chapter 94C of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting at the end thereof the following 2 subsections:-
(f) State and municipal law enforcement personnel and emergency medical personnel to include, but not limited to, emergency medical technicians (EMTs), paramedics, and fire department personnel may provide and transfer an opioid antagonist, which may include naloxone, to an individual or to the individual’s responsible family member, friend, or other person, along with instructions on administration and use of the opioid antagonist, to provide opioid overdose protection to the individual. Said provision and transfer of an opioid antagonist shall be based upon the good faith judgement of the law enforcement or emergency medical personnel including but not limited to their experience, training, knowledge, observations and the information provided by the individual at substantial risk of experiencing an opioid-related overdose event or from the individual’s family, friend or others with knowledge of the individual’s prior opioid use.
(g) A person acting in good faith may provide, administer or utilize testing equipment to assist another person in identifying or in analyzing the strength, effectiveness or purity of a controlled substance. A person who, in good faith, provides, administers or utilizes testing equipment to assist another person in identifying or in analyzing the strength, effectiveness or purity of a controlled substance shall not be charged or prosecuted for possession of drug paraphernalia under section 32I. Testing equipment shall include, but not be limited to, fentanyl test strips, colorimetric reagents, high-performance liquid chromatography, gas chromatography and mass spectrometry.
SECTION 2. Section 201 of chapter 111, as so appearing, is hereby amended by inserting after the first paragraph the following paragraph:-
Such first aid training shall also require instruction to administer opioid antagonists, which may include naloxone, in overdosing emergencies. The instruction shall meet the standards prescribed by the department. Police and fire members, shall satisfactorily complete an initial instruction as soon as practical, but in no event more than 1 year after the date of their employment. Notwithstanding, police and fire members who began their employment before the effective date of the training requirement prescribed under this paragraph, shall satisfactorily complete their instruction as soon as practical, but in no event more than 1 year after said date. Satisfactory completion of a refresher course in administering opioid antagonists as approved by the department shall be required every 3 years, unless the department by regulation establishes an earlier time requirement.
SECTION 3. Said chapter 111, as so appearing, is hereby amended by inserting after section 201, the following section:-
Section 201½. (a) As used in this section, the following words, unless the context clearly requires otherwise, shall have the following meanings:-
“Emergency first response vehicle”, any official government motor vehicle and motorized watercraft, which is intended and primarily operated to provide for the transport and rapid response of first responders to emergencies involving the public.
“First responders”, members of police and fire departments, members of the state police participating in highway patrol, and members of emergency reserve units of a volunteer fire department or fire protection district, who are trained to administer an opioid antagonist pursuant to the first aid training requirements under section 201; provided however, that first responders shall not include police officers, fire fighters and persons engaged in police and fire work whose duties are primarily clerical or administrative.
“Opioid antagonist”, Naloxone or other drug approved by the federal Food and Drug Administration as a competitive narcotic antagonist used in the reversal of overdoses caused by opioids and that is in a form approved by the commissioner for use by first responders; provided any dosage of such drug, including any integrated delivery system to administer the drug (i) is not expired under its labelled expiration date, and (ii) has no damage or other condition, determinable by visual inspection or known information, that would affect adversely the drug’s use or suitability.
(b) A governmental entity or organization shall be responsible to provide its first responders when on duty with an opioid antagonist for use in opioid overdose emergencies. This requirement shall be complied with by implementing one, or any part or combination, of the following methods: (i) equipping with an opioid antagonist any emergency first response vehicle that it owns or has care and control, or (ii) supplying an opioid antagonist to its first responders to be carried by such persons when on duty; provided the selected method when implemented shall provide all first responders with reasonable direct access to an opioid antagonist in overdose emergencies.
(c) The requirement of a government entity or organization to provide its first responders with an opioid antagonist under this section, shall be subject to such drug’s availability, provided the government entity or organization has taken reasonable measures as soon as practicable, to acquire and replenish its supply of an obtainable opioid antagonist to comply with this requirement.
(d) No cost shall be assessed to first responders by their employing or appointing governmental entity or organization for any opioid antagonist required under this section to be supplied or made available to first responders, including any device necessary for first responders to carry the drug when on duty, which shall be provided by such entity or organization.
(e) The immunity provisions established under subsection (g) of section 19B of chapter 94C shall also apply to first responders who administer an opioid antagonist in accordance with to said subsection.
SECTION 4. Subsections (b) through (d), inclusive, of Section 2 shall take effect 8 months after the passage of this act.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.